Comprehensive Analysis of the Candidate Genes CCL2,CCR2, and TLR4 in Age-Related Macular Degeneration
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine whether variants in the candidate genes TLR4, CCL2, and CCR2 are associated with age-related macular degeneration (AMD). METHODS: This study was performed in two independent Caucasian populations that included 357 cases and 173 controls from the Netherlands and 368 cases and 368 controls from the United States. Exon 4 of the TLR4 gene and the promoter, all exons, and flanking intronic regions of the CCL2 and CCR2 genes were analyzed in the Dutch study and common variants were validated in the U.S. study. Quantitative (q)PCR reactions were performed to evaluate expression of these genes in laser-dissected retinal pigment epithelium from 13 donor AMD and 13 control eyes. RESULTS: Analysis of single nucleotide polymorphisms (SNPs) in the TLR4 gene did not show a significant association between D299G or T399I and AMD, nor did haplotypes containing these variants. Univariate analyses of the SNPs in CCL2 and CCR2 did not demonstrate an association with AMD. For CCR2, haplotype frequencies were not significantly different between cases and controls. For CCL2, one haplotype containing the minor allele of C35C was significantly associated with AMD (P = 0.03), but this did not sustain after adjustment for multiple testing (q = 0.30). Expression analysis did not demonstrate altered RNA expression of CCL2 and CCR2 in the retinal pigment epithelium from AMD eyes (for CCL2 P = 0.62; for CCR2 P = 0.97). CONCLUSIONS: No evidence was found of an association between TLR4, CCR2, and CCL2 and AMD, which implies that the common genetic variation in these genes does not play a significant role in the etiology of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequent studies, for example by Despriet and Edwards, however, demonstrated no significant association of the D299G TLR4 SNP with AMD risk (Despriet et al., 2008; Edwards et al., 2008).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Despriet et al., 2008
In the citing paper
“an association between the D299G TLR4 variant and AMD was initially reported (176) but has not been validated (36, 39).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [36]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 1×
“Prog Retin Eye Res 2001;20(6): 705–732.”
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationHageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Self-citationMichelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Toll-like receptors in the pathogenesis of human disease
Cook, D. N., Pisetsky, D. S., & Schwartz, D. A. (2004) · Nature Immunology · doi:10.1038/ni1116 · Cited by 832
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Toll-Like Receptors: Linking Innate and Adaptive Immunity
Pasare, C., & Medzhitov, R. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-387-24180-9_2 · Cited by 660
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599
Toll-like receptors: linking innate and adaptive immunity
Pasare, C., & Medzhitov, R. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.018 · Cited by 453
Despriet, D. D. G., Klaver, C. C. W., Witteman, J. C. M., Bergen, A. A. B., Kardys, I., de Maat, M. P. M., Boekhoorn, S. S., Vingerling, J. R., Hofman, A., Oostra, B. A., et al. (2006) · JAMA · doi:10.1001/jama.296.3.301 · Cited by 348
Self-citationThe Risk and Natural Course of Age-Related Maculopathy: Follow-up at 6½ Years in the Rotterdam Study
van Leeuwen, R. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.519 · Cited by 332
Szalai, C., Duba, J., Prohászka, Z., Kalina, Á., Szabó, T., Nagy, B., Horváth, L., & Császár, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00423-3 · Cited by 317
Gonzalez, E., Rovin, B. H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S., Kulkarni, H., Bamshad, M. J., Telles, V., Anderson, S. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202357499 · Cited by 302
Ioannidis, J. P. A., Rosenberg, P. S., Goedert, J. J., Ashton, L. J., Benfield, T. L., Buchbinder, S. P., Coutinho, R. A., Eugen-Olsen, J., Gallart, T., Katzenstein, T. L., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00008 · Cited by 300
Zareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190
Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells
Parker, L. C., Whyte, M. K. B., Vogel, S. N., Dower, S. K., & Sabroe, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4977 · Cited by 99
Kindzelskii, A. L., Elner, V. M., Elner, S. G., Yang, D., Hughes, B. A., & Petty, H. R. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409062 · Cited by 85
Kaur, I., Hussain, A., Hussain, N., Das, T., Pathangay, A., Mathai, A., Hussain, A., Nutheti, R., Nirmalan, P. K., & Chakrabarti, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1430 · Cited by 84
Valdes, A. M., Wolfe, M. L., O’Brien, E. J., Spurr, N. K., Gefter, W., Rut, A., Groot, P. H. E., & Rader, D. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000038486.48400.e7 · Cited by 78
Guidelines for association studies in Human Molecular Genetics
Freimer, N. B., & Sabatti, C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi251 · Cited by 78
Soest, S. V., de Wit, G. M. J., Essing, A. H. W., ten Brink, J. B., Kamphuis, W., de Jong, P. T. V. M., & Bergen, A. A. B. (2007) · PubMed · Cited by 66
Self-citationCCR2 Genotype and Disease Progression in a Treated Population of HIV Type 1-Infected Women
Philpott, S. M., Burger, H., Tarwater, P. M., Lu, M., Gange, S. J., Anastos, K., Cohen, M. H., Greenblatt, R. M., Kovacs, A., MINKOFF, H. L., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423386 · Cited by 9
Cited by
Inflammation and its role in age-related macular degeneration
Kauppinen, A., Paterno, J. J., Blasiak, J., Salminen, A., & Kaarniranta, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2147-8 · Cited by 649
“However, a study conducted with AMD patients and control subjects from The Netherlands and the US, detected no associations between CCL2, CCR2, or TLR4 and AMD [172].”
ResultMolecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“Subsequent studies, for example by Despriet and Edwards, however, demonstrated no significant association of the D299G TLR4 SNP with AMD risk (Despriet et al., 2008; Edwards et al., 2008).”
ResultAnimal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
“However, screening of the Ccl2 and Ccr2 loci have yet to reveal any at risk alleles associated with the development of AMD (Despriet et al., 2008).”
BackgroundSwaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164350 · Cited by 270
“Toll-like receptor 4 (TLR4) was considered an attractive candidate due to its key role in innate immunity, potential function in phagocytosis, and location to a region that exhibits some evidence of linkage to AMD; an association between the D299G TLR4 variant and AMD was initially reported (176) but has not been vali…”
Luhmann, U. F. O., Robbie, S., Munro, P. M. G., Barker, S. E., Duran, Y., Luong, V., Fitzke, F. W., Bainbridge, J. W. B., Ali, R. R., & MacLaren, R. E. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3462 · Cited by 205
Metadata
- Authors
- Despriet, D. D. G., Bergen, A. A. B., Merriam, J. E., Zernant, J., Barile, G. R., Smith, R. T., Barbazetto, I. A., van Soest, S., Bakker, A., de Jong, P. T. V. M., Allikmets, R., & Klaver, C. C. W.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- Departments of Ophthalmology and
- From the Department of Clinical and Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands; the
- From the Department of Clinical and Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands; the3Epidemiology and Biostatistics, Erasmus Medical Center, Rotterd
- Columbia University (US)
- ORCID
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2008-01-01
- Volume
- 49
- Issue
- 1
- Pages
- 364
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- PMC
- PMC2754756
- OpenAlex
- W2054073735
- Cited by
- 60
- References
- 30
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 1 · 2012: 7
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- National Eye Institute (EY-017404, R01EY013435, EY-13435, R01EY015520, R24EY017404)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, MCP-1, CCR2, TLR4, single nucleotide polymorphisms, genetic association, haplotypes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alleles, DNA Mutational Analysis, Exons, Female, Haplotypes, Humans, Macular Degeneration, Male, Middle Aged, Polymerase Chain Reaction, Chemokine CCL2, Polymorphism, Single Nucleotide, White People, Toll-Like Receptor 4, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.